Catalyst event

Alnylam Pharmaceuticals Inc (ALNY)

From Akros U.S. Large Cap 500 Protective Allocation Monthly Index (A500PAM)

Alnylam is scheduled to report second-quarter 2026 financial results before U.S. market open on July 30, 2026.

Korean translation

알나일람은 2026년 7월 30일 미국 장 개시 전에 2026년 2분기 실적을 발표할 예정임.